A Phase Ib/II Study of the Safety and Immunogenicity of the Candidate Rabies Vaccine ChAdOx2 RabG
Clinical trial NCT04270838 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04270838
- Sponsor
- University of Oxford
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-17
- Primary completion
- 2028-09-01
- Enrollment
- 174
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.